Table: Cosmos Pharmaceutical -2023/24 parent results

Cosmos Pharmaceutical

12/07/2024 07:00

Jul 12 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              May 31, 2024    May 31, 2023   May 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          964.99          827.70                                
               (+16.6 pct)     (+9.6 pct)                              
  Operating       31.48           30.10                                
               (+4.6 pct)      (+1.1 pct)                              
  Recurring       34.29           33.07                                
               (+3.7 pct)      (+0.7 pct)                              
  Net             24.45           23.79                                
               (+2.8 pct)      (+2.8 pct)                              
  EPS          617.02 yen      600.71 yen                              
  Ann Div      120.00 yen      100.00 yen      65.00 yen               
  -Q2 Div       60.00 yen       42.50 yen      32.50 yen               
  -Q4 Div       60.00 yen       57.50 yen      32.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T